➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Colorcon
Johnson and Johnson
Boehringer Ingelheim
McKesson

Last Updated: July 23, 2021

DrugPatentWatch Database Preview

DIGOXIN - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic sources for digoxin and what is the scope of freedom to operate?

Digoxin is the generic ingredient in five branded drugs marketed by Glaxosmithkline Llc, Hikma, Vistapharm, Abraxis Pharm, Hospira, Sandoz Inc, West-ward Pharms Int, Wyeth Ayerst, Covis, Hikma Intl Pharms, Impax Labs, Mylan Pharms Inc, Stevens J, Sun Pharm Inds Inc, and Concordia, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for digoxin. Ten suppliers are listed for this compound.

Drug Prices for DIGOXIN

See drug prices for DIGOXIN

Drug Sales Revenue Trends for DIGOXIN

See drug sales revenues for DIGOXIN

Recent Clinical Trials for DIGOXIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Tanta UniversityPhase 2
Mirati Therapeutics Inc.Phase 1
I.M. Sechenov First Moscow State Medical UniversityPhase 4

See all DIGOXIN clinical trials

Pharmacology for DIGOXIN
Medical Subject Heading (MeSH) Categories for DIGOXIN

US Patents and Regulatory Information for DIGOXIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira DIGOXIN PEDIATRIC digoxin INJECTABLE;INJECTION 040092-001 Apr 25, 1996 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Concordia LANOXIN digoxin TABLET;ORAL 020405-004 Sep 30, 1997 AB RX Yes Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Impax Labs DIGOXIN digoxin TABLET;ORAL 078556-002 Jul 20, 2009 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for DIGOXIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline Llc LANOXICAPS digoxin CAPSULE;ORAL 018118-002 Jul 26, 1982 ⤷  Try it Free ⤷  Try it Free
Glaxosmithkline Llc LANOXICAPS digoxin CAPSULE;ORAL 018118-004 Sep 24, 1984 ⤷  Try it Free ⤷  Try it Free
Glaxosmithkline Llc LANOXICAPS digoxin CAPSULE;ORAL 018118-001 Jul 26, 1982 ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Colorcon
Johnson and Johnson
Boehringer Ingelheim
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.